ResearcherAnhui Medical UniversityNo recent work listed

Shengquan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6098-1208; OpenAlex author ID A5076962436. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 2 papers

Papers 2

Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ijo.2021.5235 ↗
Cholesterol biosynthesis inhibitor RO 48‑8071 inhibits pancreatic ductal adenocarcinoma cell viability by deactivating the JNK and ERK/MAPK signaling pathway. Co-author DOI 10.3892/mmr.2021.12468 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yeben Qian · 1 shared paper, 2021 · strength 0.13
- Paper Cholesterol biosynthesis inhibitor RO 48‑8071 inhibits pancreatic ductal adenocarcinoma cell viability by deactivating … DOI 10.3892/mmr.2021.12468 ↗
Zhen Ding · 1 shared paper, 2021 · strength 0.13
- Paper Cholesterol biosynthesis inhibitor RO 48‑8071 inhibits pancreatic ductal adenocarcinoma cell viability by deactivating … DOI 10.3892/mmr.2021.12468 ↗
Li Liu · 1 shared paper, 2021 · strength 0.12
- Paper Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.3892/ijo.2021.5235 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.